uniQure Investors Alert: Important Class Action Deadline Approaches for Securities Claims
uniQure Investors Alert: Securities Class Action Deadline Approaches
As the deadline for a significant securities class action against uniQure N.V. approaches, investors are urged to take immediate action. Faruqi & Faruqi, a prominent national securities law firm, is spearheading efforts to support potential claimants. They remind investors of the deadline on April 13, 2026, to participate in this important legal undertaking. This article outlines the critical developments surrounding this case, and what investors need to know.
Background of the Case
The firm has begun an investigation related to claims against uniQure, listed under NASDAQ as QURE. The firm alleges that uniQure and its executives may have violated federal securities laws by disseminating false or misleading statements, as well as failing to disclose essential information. One pivotal point of concern is the status of uniQure’s Pivotal Study results which did not receive full FDA approval, a claim the company previously concealed.
In recent disclosures, uniQure revealed that FDA officials
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.